9/18/23 18:54 | 9/15/23 | ADVM | Health | BioPrd | Biological Products, (No Diag | Seyedkazemi Setareh | CA | O | Chief De | S | -9 | 1.52 | 0 | -6 | -12 | 48 | D | | | | | | | | | | | | | | |
3/17/23 18:02 | 3/15/23 | ADVM | Health | BioPrd | Biological Products, (No Diag | Riley Brigit | CA | O | Chief Sc | S | -6 | 0.7816 | 0 | -7 | -6 | 117 | D | | | | | | | | | | | | | | |
3/17/23 18:02 | 3/15/23 | ADVM | Health | BioPrd | Biological Products, (No Diag | Soparkar Peter | CA | O | COO | S | -10 | 0.7816 | 0 | -13 | -5 | 266 | D | | | | | | | | | | | | | | |
3/17/23 18:01 | 3/15/23 | ADVM | Health | BioPrd | Biological Products, (No Diag | Fischer Laurent | CA | DO | CEO,P,Di | S | -32 | 0.7816 | 0 | -41 | -6 | 692 | D | | | | | | | | | | | | | | |
9/21/22 20:01 | 9/19/22 | ADVM | Health | BioPrd | Biological Products, (No Diag | Beckman Richard | CA | O | Chief Me | S | -5 | 1.07 | 0 | -4 | -10 | 39 | D | | | | | | | | | | | | | | |
9/21/22 20:00 | 9/19/22 | ADVM | Health | BioPrd | Biological Products, (No Diag | Seyedkazemi Setareh | CA | O | Chief De | S | -6 | 1.07 | 0 | -6 | -11 | 48 | D | | | | | | | | | | | | | | |
9/21/22 19:59 | 9/19/22 | ADVM | Health | BioPrd | Biological Products, (No Diag | Soparkar Peter | CA | O | See Rema | S | -14 | 1.07 | 0 | -13 | -5 | 273 | D | | | | | | | | | | | | | | |
9/21/22 19:58 | 9/19/22 | ADVM | Health | BioPrd | Biological Products, (No Diag | Riley Brigit | CA | O | Chief Sc | S | -8 | 1.07 | 0 | -7 | -6 | 119 | D | | | | | | | | | | | | | | |
9/21/22 19:57 | 9/19/22 | ADVM | Health | BioPrd | Biological Products, (No Diag | Fischer Laurent | CA | DO | CEO,P,Di | S | -44 | 1.07 | 0 | -41 | -5 | 727 | D | | | | | | | | | | | | | | |
11/17/21 16:38 | 11/15/21 | ADVM | Health | BioPrd | Biological Products, (No Diag | Scopa James Paul | CA | D | | S | -109 | 2.18 | 0 | -50 | -94 | 3 | I | | | | | | | | | | | | | | |
10/4/21 17:36 | 9/30/21 | ADVM | Health | BioPrd | Biological Products, (No Diag | Clark Julie | CA | O | Chief Me | S | -10 | 2.17 | 0 | -5 | -3 | 165 | D | | | | | | | | | | | | | | |